Yanda International Hospital
Benign prostatic hyperplasia (BPH) treatment cost in China typically runs from $8,200 to $13,800 for laser vaporization procedures. More advanced robotic da Vinci prostatectomy usually ranges from $18,800 to $27,800. Total expenses depend on the surgical technique, hospital stay duration, and the inclusion of traditional medicine. Patients can save 40-60% compared to US prices. Top cities include Beijing, Guangzhou, and Dalian.
Typical Benign Prostatic Hyperplasia (BPH) Treatment Costs in China
Bookimed Expert Insight: Patients seeking integrated care should consider JCI-accredited centers like Yanda International Hospital. They combine international surgery protocols with traditional Chinese medicine for better recovery. Those requiring advanced technology benefit from Fuda Cancer Hospital's expertise in minimally invasive therapies. For complex prostate enlargement, robotic-assisted surgery at Class A level III facilities ensures higher precision. Professor Wang He Tian at Yanda is a top choice for conservative and andrology-focused treatments.
| China | Turkey | Austria | |
| Vaporization (with GreenLight Laser) | from $8,200 | from $1,800 | from $6,000 |
| Transurethral microwave therapy (TUMT) | from $1,800 | from $2,000 | from $3,500 |
| Transurethral incision of the prostate (TUIP) | from $3,800 | from $2,200 | from $3,500 |
| Transurethral Water Vapour Ablation | from $7,200 | from $2,200 | from $4,000 |
| Robotic da Vinci prostatectomy | from $18,800 | from $17,000 | from $20,000 |
Head of Traditional Chinese Medicine at Yanda International Hospital – specializes in prostate diseases and complex cases with integrative approaches.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
Chinese hospitals treat benign prostatic hyperplasia using a combination of Western pharmaceuticals, minimally invasive surgeries, and traditional medicine. Standard protocols include alpha-blockers like Tamsulosin and 5-alpha reductase inhibitors like Finasteride. JCI-accredited facilities in Beijing and Guangzhou also offer advanced robotic-assisted prostatectomy.
Bookimed Expert Insight: Yanda International Hospital and Fuda Cancer Hospital demonstrate how China bridges high-tech and traditional care. While Yanda serves 2,500,000 patients annually using 28,500 technologies, experts like Dr. Wang He Tian integrate specialized andrology knowledge. Patients should prioritize Class A level III clinics in Tier-1 cities to access both JCI safety standards and high-volume surgical expertise.
Patient Consensus: Patients note it is important to verify surgeon volume and often choose Tier-1 cities for laser procedures. Many find that starting with cost-effective medications provides relief before considering surgical options like TURP or HoLEP.
Traditional Chinese Medicine (TCM) integrates into China's benign prostatic hyperplasia (BPH) care through a combined medicinal model. Physicians use herbal formulas and acupuncture alongside Western alpha-blockers to manage urinary symptoms. This integrative approach is standard in high-level JCI-accredited facilities like Yanda International Hospital.
Bookimed Expert Insight: Data from top-tier academic centers like Yanda International Hospital shows a unique structural advantage. Their TCM-Joint Center combines traditional expertise with over 28,500 modern technologies. This allows specialists like Prof. Wang He Tian to lead departments focused specifically on integrative urological care. Patients benefit from a system that balances herbal recovery protocols with advanced robotic surgery capabilities in one facility.
Patient Consensus: Patients note that doctors often start with 2–4 weeks of herbal therapy before considering surgery. They emphasize that staying consistent with nightly herbal decoctions is vital to avoid needing a catheter.
Leading Chinese centers like Yanda International Hospital and Fuda Cancer Hospital are globally recognized for high-volume benign prostatic hyperplasia treatment. These JCI-accredited facilities utilize advanced GreenLight laser vaporization and cryosurgery. Expert surgeons often manage over 9,000 procedures annually while maintaining rigorous safety standards.
Bookimed Expert Insight: Yanda International Hospital stands out by combining Western surgical precision with traditional protocols. It holds the Class A Level III status, which is the highest medical tier in China. This designation typically ensures access to the most advanced diagnostic equipment. Data shows it serves 2.5 million patients yearly, indicating a massive infrastructure for handling international volume.
Patient Consensus: Patients note that language support is essential when choosing Chinese tertiary centers for care. While surgical outcomes are praised, many recommend confirming English-speaking staff availability before arrival for complex procedures.
Chinese urologists recommend invasive therapy for Benign Prostatic Hyperplasia when conservative treatments fail. Diagnostic thresholds include a peak flow rate below 10 ml/s and residual urine exceeding 50 ml. Specialists also require a prostate volume over 50–80cc and high symptom scores before surgical intervention.
Bookimed Expert Insight: Clinical practice at Class A level III facilities like Yanda International Hospital often bridges traditional and modern standards. While general guidelines exist, specialists like Dr. Wang He Tian integrate Chinese medical books with international protocols. This approach often results in a meds-first strategy until physiological thresholds are strictly met. Patients should prepare for detailed tracking of monthly symptoms to support requests for advanced surgical escalations.
Patient Consensus: Patients note that doctors in Tier 1 cities often prioritize medical management with alpha-blockers. Many emphasize bringing complete medical records from home to avoid delays in surgical decision-making.
Newer Chinese laser techniques protect sexual function by using specific light wavelengths that limit thermal penetration. High-power 450 nm blue lasers and 1470 nm diode lasers minimize heat damage to erectile nerves. Modified surgical steps further spare the ejaculatory ducts and bladder neck mucosa.
Bookimed Expert Insight: Leading Chinese urologists like Dr. Wang He Tian integrate Western laser technology with Traditional Chinese Medicine (TCM) protocols. Data from high-volume centers suggests that this multidisciplinary approach helps manage pelvic blood flow. Facilities like Tianjin Jin Xian Tan Hospital perform approximately 9,000 operations annually. This high procedural volume is a strong indicator of surgical precision in nerve-sparing techniques. Patients should prioritize hospitals with class A level III status to ensure access to these specific blue laser platforms.
Patient Consensus: Patients note it is important to ask about ejaculation-preserving modes before the procedure. Those who choose thulium or holmium lasers often track their own sexual health scores to ensure recovery remains on target.
Recovery after BPH surgery in China typically requires a 2 to 5-day hospital stay. Patients generally achieve full healing within 4 to 6 weeks. Short flights are possible after 10 days. Most experts recommend waiting 6 weeks before embarking on long-haul air travel.
Bookimed Expert Insight: While many Chinese centers like Yanda International Hospital offer traditional TURP, choosing laser-based procedures like Holmium Laser Enucleation can accelerate travel readiness. Our data shows these minimally invasive techniques often reduce catheter time to just 48 hours. This allows international patients to transition to local hotels faster than with conventional surgery.
Patient Consensus: Patients emphasize the need for a 1-hour trial car trip before booking flights. They often suggest waiting until week 10 for international travel to ensure any late-stage swelling has fully subsided.
Patients seeking treatment for benign prostatic hyperplasia in China should prioritize facilities with Tertiary Grade A (Class 3A) status. This national ranking ensures the highest standards for surgical equipment and clinical outcomes. International Joint Commission International (JCI) accreditation and National Medical Products Administration (NMPA) registration for lasers or robotic systems are also vital quality indicators.
Bookimed Expert Insight: Data shows a significant gap between local ratings and international safety benchmarks. While many hospitals hold Class 3A status, only specialized centers like Yanda International Hospital or Fuda Cancer Hospital maintain Joint Commission International (JCI) accreditation. For complex prostate cases, choosing a JCI-accredited facility in Beijing or Guangzhou often provides better access to multi-lingual support and internationally audited safety protocols.
Patient Consensus: Patients emphasize the need to verify surgeon case volumes personally rather than relying solely on government approvals. Many note that prioritizing English-speaking hubs with clear international audits helps avoid communication gaps and ensures more reliable post-operative follow-up plans.
Chinese hospitals treat benign prostatic hyperplasia (BPH) using minimally invasive surgical techniques. Primary options include bipolar plasmakinetic resection, holmium laser enucleation (HoLEP), and robotic-assisted surgeries. These methods help clear urinary blockages and restore flow. Most procedures use transurethral access to avoid external incisions.
Bookimed Expert Insight: Yanda International Hospital in Beijing operates as a Class A level III facility. This is the highest medical tier in China. The hospital manages over 2,000,000 patients annually across 39 departments. Patients gain access to JCI-accredited care that combines modern robotic technology with traditional andrology expertise. This dual approach is common in Chinese multidisciplinary centres.
Patient Consensus: Patients note that Chinese hospitals mirror international standards. They offer various transurethral and laser-based techniques. Patients appreciate that specialists often consider minimally invasive alternatives to chemotherapy when treating complex prostate conditions in Guangzhou.
Recovery after a HoLEP procedure in China is generally rapid. This is due to its minimally invasive nature. Most patients leave the hospital within 1–2 days. Bladder discomfort usually settles within 2 weeks. Full stability of urinary flow is typically achieved within 6 weeks.
Bookimed Expert Insight: While HoLEP is the surgical standard, major Chinese centres serve many patients annually. Yanda International Hospital, for example, serves 2,500,000 people each year. These centres often integrate traditional treatments with Western laser surgery. Specialists like Professor Wang He Tian may combine these approaches. This helps recovery from chronic urological inflammation after the primary procedure.
Yanda International Hospital and Fuda Cancer Hospital are leading centres for benign prostatic hyperplasia (BPH) treatment in China. These facilities are reputable for high surgical volumes and JCI-accredited safety standards. They specialise in laser therapies and robotic-assisted procedures for prostate enlargement. Most major Chinese centres use GreenLight laser vapourisation and robotic systems.
Bookimed Expert Insight: Many international patients seek specific surgical brands like da Vinci. However, China's unique advantage is integrating traditional protocols with Western surgery. Prof. Dr Wang He Tian at Yanda International Hospital heads a department using this combined approach. This can be beneficial for long-term recovery and rehabilitation after major prostate procedures.
Patient Consensus: Patients recommend large tertiary teaching hospitals in cities like Beijing or Guangzhou for BPH surgery. They note that high-volume urology departments manage aftercare effectively. These centres often outperform smaller, marketing-focused private clinics for medication adjustment.
Traditional Chinese Medicine (TCM) is frequently used in China to manage symptoms of Benign Prostatic Hyperplasia (BPH). Leading JCI-accredited clinics often combine herbal therapies with modern surgery. Specialists use integrated protocols to treat urinary frequency and flow issues. They also address hormone levels and prostate inflammation.
Bookimed Expert Insight: Top medical centres like Yanda International Hospital treat over 2,500,000 patients annually. This massive volume allows specialists to refine treatments combining TCM with high-tech urology. Australian patients should note that TCM works best for symptom relief alongside laser vaporisation.
Patient Consensus: Patients find TCM helps with urinary frequency. However, they recommend getting a full urological workup first. In China, TCM is usually an add-on to standard surgical or drug-based care.